Endovia Health Sciences, Inc.
EDVA
22 hedge funds and large institutions have $2.19M invested in Endovia Health Sciences, Inc. in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
971% more call options, than puts
Call options by funds: $225K | Put options by funds: $21K
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0% more funds holding
Funds holding: 22 → 22 (0)
0% more ownership
Funds ownership: 0.03% → 0.04% (+0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
23% less capital invested
Capital invested by funds: $2.83M → $2.19M (-$643K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$148K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$134K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$87.2K |
| 4 |
Millennium Management
New York
|
+$17K |
| 5 |
SG
StoneX Group
New York
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$110K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$41K |
| 3 |
VF
Virtu Financial
New York
|
-$32.5K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$21K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$12.8K |
EDVA Hedge Fund Activity: Q4 2022 in Review
22 of the 6,236 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q4 2022, worth a combined $2.19M — down 23% from $2.83M a quarter earlier.
Fund positioning in EDVA was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $148K. The largest seller was Parsons Capital Management, cutting an estimated $110K.
- 22 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $2.19M of Endovia Health Sciences, Inc. stock for Q4 2022, down 23% quarter-over-quarter.
- 4 funds opened new Endovia Health Sciences, Inc. positions in Q4 2022 and 4 closed out, a net change of 0 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q4 2022 was Citadel Advisors, an estimated $148K added.
- The largest Endovia Health Sciences, Inc. seller in Q4 2022 was Parsons Capital Management, an estimated $110K sold.
Based on aggregated 13F filings for Q4 2022.